Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 16
2003 13
2004 10
2005 11
2006 11
2007 15
2008 14
2009 17
2010 9
2011 12
2012 19
2013 18
2014 13
2015 11
2016 17
2017 17
2018 18
2019 10
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

243 results
Results by year
Filters applied: . Clear all
Page 1
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.
Shimano H, Sato R. Shimano H, et al. Nat Rev Endocrinol. 2017 Dec;13(12):710-730. doi: 10.1038/nrendo.2017.91. Epub 2017 Aug 29. Nat Rev Endocrinol. 2017. PMID: 28849786 Review.
CREBH Regulates Systemic Glucose and Lipid Metabolism.
Nakagawa Y, Shimano H. Nakagawa Y, et al. Among authors: shimano h. Int J Mol Sci. 2018 May 8;19(5):1396. doi: 10.3390/ijms19051396. Int J Mol Sci. 2018. PMID: 29738435 Free PMC article. Review.
SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism.
Oishi Y, Spann NJ, Link VM, Muse ED, Strid T, Edillor C, Kolar MJ, Matsuzaka T, Hayakawa S, Tao J, Kaikkonen MU, Carlin AF, Lam MT, Manabe I, Shimano H, Saghatelian A, Glass CK. Oishi Y, et al. Among authors: shimano h. Cell Metab. 2017 Feb 7;25(2):412-427. doi: 10.1016/j.cmet.2016.11.009. Epub 2016 Dec 29. Cell Metab. 2017. PMID: 28041958 Free PMC article.
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P. Fruchart JC, et al. Among authors: shimano h. Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Cardiovasc Diabetol. 2019. PMID: 31164165 Free PMC article. Review.
The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice.
Araki M, Nakagawa Y, Oishi A, Han SI, Wang Y, Kumagai K, Ohno H, Mizunoe Y, Iwasaki H, Sekiya M, Matsuzaka T, Shimano H. Araki M, et al. Among authors: shimano h. Int J Mol Sci. 2018 Jul 23;19(7):2148. doi: 10.3390/ijms19072148. Int J Mol Sci. 2018. PMID: 30041488 Free PMC article.
Transcriptome network analysis identifies protective role of the LXR/SREBP-1c axis in murine pulmonary fibrosis.
Shichino S, Ueha S, Hashimoto S, Otsuji M, Abe J, Tsukui T, Deshimaru S, Nakajima T, Kosugi-Kanaya M, Shand FH, Inagaki Y, Shimano H, Matsushima K. Shichino S, et al. Among authors: shimano h. JCI Insight. 2019 Jan 10;4(1):e122163. doi: 10.1172/jci.insight.122163. Online ahead of print. JCI Insight. 2019. PMID: 30626759 Free PMC article.
Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone H. Kodama S, et al. Among authors: shimano h. JAMA. 2009 May 20;301(19):2024-35. doi: 10.1001/jama.2009.681. JAMA. 2009. PMID: 19454641
[Sulfonylureas].
Kobayashi K, Shimano H. Kobayashi K, et al. Among authors: shimano h. Nihon Rinsho. 2012 May;70 Suppl 3:602-7. Nihon Rinsho. 2012. PMID: 22768585 Japanese. No abstract available.
Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
Matsuzaka T, Kuba M, Koyasu S, Yamamoto Y, Motomura K, Arulmozhiraja S, Ohno H, Sharma R, Shimura T, Okajima Y, Han SI, Aita Y, Mizunoe Y, Osaki Y, Iwasaki H, Yatoh S, Suzuki H, Sone H, Takeuchi Y, Yahagi N, Miyamoto T, Sekiya M, Nakagawa Y, Ema M, Takahashi S, Tokiwa H, Shimano H. Matsuzaka T, et al. Among authors: shimano h. Hepatology. 2020 May;71(5):1609-1625. doi: 10.1002/hep.30953. Epub 2020 Feb 7. Hepatology. 2020. PMID: 31529722
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?
Fruchart JC, Santos RD, Yamashita S, Libby P; International Atherosclerosis Society/R3i Foundation Consensus Panel. Fruchart JC, et al. Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2723-2725. doi: 10.1016/j.dsx.2019.05.034. Epub 2019 May 30. Diabetes Metab Syndr. 2019. PMID: 31405699 Review. No abstract available.
243 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback